激素替代治疗-冻融胚胎移植周期中补充促性腺激素释放激素激动剂:一项随机对照试验
这项随机对照试验纳入2013至2019年间287个激素替代治疗-冻融胚胎移植周期,评估在标准方案基础上补充两剂曲普瑞林0.1毫克是否降低总妊娠丢失率。结果显示,GnRHa组与对照组的总妊娠丢失率(21%对33%;RR 0.63,95%CI 0.35-1.11)及每例阳性HCG的生化妊娠丢失率(12%,8/67对25%,18/72;RR 0.48,95%CI 0.22-1.02)均无显著差异;有活产的参与者平均孕酮浓度显著高于无活产者。
要点
- 补充两剂曲普瑞林0.1毫克未显著降低总妊娠丢失率(21%对33%;RR 0.63,95%CI 0.35-1.11)。
- 每例阳性HCG的生化妊娠丢失率GnRHa组12%(8/67)对对照组25%(18/72),RR 0.48(95%CI 0.22-1.02),无显著差异。
- 有活产者平均孕酮浓度显著高于无活产者(25.0±12.2对23.8±8.9 nmol/l;P=0.001)。
核心结论
- 尽管GnRHa补充组生化妊娠丢失率低14%、总妊娠丢失率低12%,但均未达统计学差异。
- 黄体期孕酮和雌二醇浓度与激素替代治疗-冻融胚胎移植周期的活产率相关,强调监测黄体期血清孕酮和雌二醇的重要性。
研究设计与样本
- 随机对照试验,纳入2013至2019年间共287个激素替代治疗-冻融胚胎移植周期。
- GnRHa组(n=144)在标准激素替代治疗方案基础上补充两剂曲普瑞林0.1毫克:开始阴道孕酮前2天一剂,孕酮第7天一剂。
- 对照组(n=143)仅接受标准激素替代治疗-冻融胚胎移植方案。
主要发现
- 意向性分析显示GnRHa组与对照组总妊娠丢失率无显著差异(21%对33%;RR 0.63,95%CI 0.35-1.11)。
- 每例阳性HCG的生化妊娠丢失率GnRHa组为12%(8/67),对照组为25%(18/72),RR 0.48(95%CI 0.22-1.02),无显著差异。
- 有活产的参与者平均孕酮浓度显著高于无活产者(25.0±12.2对23.8±8.9 nmol/l;P=0.001)。
- 活产率有随雌二醇最高四分位浓度(雌二醇>0.957 nmol/l)升高而增高的趋势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Will two boluses of gonadotrophin-releasing hormone agonist (GnRHa) during hormone replacement therapy-frozen embryo transfer (HRT-FET) cycles reduce the total pregnancy loss rate? DESIGN: Randomized controlled trial including a total of 287 HRT-FET cycles performed between 2013 and 2019. After randomization participants allocated to the GnRHa group (n = 144) underwent a standard HRT protocol, supplemented with a total of two boluses of triptorelin 0.1 mg; one bolus 2 days before starting vaginal progesterone and one bolus on the 7th day of progesterone. The control group (n = 143) underwent a standard HRT-FET protocol only. RESULTS: The intention-to-treat analysis showed no significant difference in total pregnancy loss between the GnRHa group and the control group (21% versus 33%; relative risk [RR] 0.63, 95% confidence interval [CI] 0.35-1.11), nor was the biochemical pregnancy loss per positive human chorionic gonadotrophin (HCG) significantly lower in the GnRHa group (12%, 8/67) compared with the control group (25%, 18/72) (RR 0.48, 95% CI 0.22-1.02). Participants with a live birth had a significantly higher mean progesterone concentration compared with participants without a live birth (25.0 ± 12.2 versus 23.8 ± 8.9 nmol/l; P = 0.001). Furthermore, a trend for a higher live birth rate (LBR) correlated with the highest oestradiol quartile concentration (oestradiol >0.957 nmol/l). CONCLUSIONS: Although a difference of 14% in biochemical loss and 12% in total pregnancy loss in favour of GnRHa supplementation was seen this did not reach statistical difference. Luteal progesterone and oestradiol concentrations correlate with LBR in the HRT-FET cycle, emphasizing the importance of luteal serum progesterone and oestradiol monitoring.
引用
- Alsbjerg B, Kesmodel US, Elbaek HO, et al. GnRH agonist supplementation in hormone replacement therapy-frozen embryo transfer cycles: a randomized controlled trial. Reprod Biomed Online. 2021. PMID: 34924287. doi:10.1016/j.rbmo.2021.10.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。